Avastin Account Orders Double, Reorder Rate Improves To 80%
This article was originally published in The Pink Sheet Daily
Executive Summary
The number of accounts ordering the oncologic rose from 1,500 to more than 3,000 in the second quarter, with 80% of accounts placing reorders. Genentech says the majority of Avastin's sales come from the front-line setting.